Day: February 22, 2021

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — Mercer International Inc. (Nasdaq: MERC) today announced that David M. Gandossi, President and CEO, will be presenting at the following upcoming conference:Raymond James 2021 Institutional Investors ConferenceWednesday, March 3rd, 2021Fireside Chat at 3:00 PM ESTA copy of the presentation will be posted in the “Investors – Current Documents” section on the Company’s web site (https://mercerint.com/investors/current-documents/) on the morning of the event.At Mercer International Inc., we are exceptional people creating bioproducts for a more sustainable world. We are a diversified global producer of forest products, bioproducts, and green electricity with operations in Germany, Canada, and Australia with a consolidated annual production capacity of approximately 2.2 million tonnes...

New York, NY, Feb. 22, 2021 (GLOBE NEWSWIRE) — FinServ Acquisition Corp. II (the “Company”) announced today that it closed its initial public offering of 30,000,000 units, including 3,500,000 units issued pursuant to the exercise of the underwriters’ over-allotment option, at $10.00 per unit. The units are listed on the Nasdaq Capital Market (“Nasdaq”) under the ticker symbol “FSRXU”. Each unit consists of one of the Company’s shares of Class A common stock and one-quarter of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable.  Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “FSRX”...

Highlights:Euro Manganese and its wholly owned Czech Republic subsidiary, Mangan Chvaletice, have secured the support of EIT InnoEnergy, a Knowledge and Innovation Community supported by the European Institute of Innovation and Technology. EIT InnoEnergy will marshal its broad network and resources to accelerate the Chvaletice Manganese Project’s successful integration into the European Union’s battery supply chain.The Chvaletice Manganese Project is the only sizeable manganese resource in the European Union, with the potential to provide up to 50% of projected 2025 European demand for high-purity manganese, and 28% of its anticipated 2030 requirements.The Project also brings local environmental and social benefits. As tailings from the decommissioned mine are recycled to produce battery-grade manganese, a longstanding source of water...

BURLINGTON, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the 42nd Annual Raymond James Institutional Investors Conference. The virtual fireside chat is scheduled to begin at 12:30 p.m. ET on Monday, March 1, 2021.To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company’s core values are focus, ingenuity,...

SPRINGDALE, Ark., Feb. 22, 2021 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN), today announced that the company is making organizational changes designed to improve operational agility, customer experience and speed of innovation to market, ensuring that all businesses are well-positioned to adapt to a dynamic environment.“Consumer preferences are changing and evolving at a rapid pace,” said Dean Banks, president and chief executive officer of Tyson Foods. “We must accelerate our pace of change to not only meet but exceed our customers’ expectations while delivering high quality, innovative products. That’s why we’re adapting our organization to enable our businesses to respond rapidly to the changing environment.”Each of Tyson Foods’ four business segments will be equipped with the resources and structure needed to enable quicker...

SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Company management will present at the following upcoming virtual investor conferences in February and March:SVB Leerink 10th Annual Global Healthcare ConferenceDate: Wednesday, February 24, 2021Time: 1:00 p.m. ETBarclays Global Healthcare ConferenceDate: Wednesday, March 10, 2021Time: 11:30 a.m. ETLive webcasts will be available at https://ir.travere.com/events-presentations and archived replays will be accessible for up to 30 days.About Travere TherapeuticsAt Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options...

NEW YORK, Feb. 22, 2021 (GLOBE NEWSWIRE) — LiveArea, a global customer experience and commerce agency, and business unit of PFSweb (NASDAQ: PFSW), today announced the appointment of Rashmi Sethi as Group Creative Director and head of the company’s newly incubated Innovation Lab and Creative Studio. The facility will centralize the company’s global work designing and building prototypes and accelerators for global clients.Sethi brings to LiveArea more than 20 years of experience working in innovation, experience design, and digital business transformation. She has a multi-disciplinary background in economics, science, and statistics, and is a practitioner of design thinking. She has led experience design and digital product innovation teams, R&D labs, creative studios, and global consulting in a variety of global companies,...

LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) (CSE:VS) (FRANKFURT:BMVB) today announced plans to withdraw its common shares from listing on the Canadian Securities Exchange (the “CSE”) effective February 25, 2021. Versus’ common shares (CUSIP 92535P808) have been traded on the CSE since 2016 under the symbol VS, the same as its Nasdaq symbol. Following the recent listing of its shares on the Nasdaq Capital Market, the Company has decided to withdraw from the CSE. Versus will continue to trade on the Nasdaq Capital Market under the symbol VS and on the Frankfurt stock exchange under the symbol BMVB and will continue to be a Canadian Reporting Issuer.About Versus SystemsVersus Systems Inc. has developed a proprietary in-game prizing and promotions engine that allows publishers,...

GAITHERSBURG, Md., Feb. 22, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its full year 2020 financial results on Thursday, February 25th, 2021.Altimmune management will host a conference call for investors beginning at 8:30 am ET on Thursday, February 25th, 2021 to discuss financial results and provide a business update.Conference Call Information:About AltimmuneAltimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation...